DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. / Dahl, Morten; Tybjaerg-Hansen, A; Lange, P; Nordestgaard, B G.

I: Lancet, Bind 351, Nr. 9120, 27.06.1998, s. 1911-3.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Dahl, M, Tybjaerg-Hansen, A, Lange, P & Nordestgaard, BG 1998, 'DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma', Lancet, bind 351, nr. 9120, s. 1911-3.

APA

Dahl, M., Tybjaerg-Hansen, A., Lange, P., & Nordestgaard, B. G. (1998). DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet, 351(9120), 1911-3.

Vancouver

Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet. 1998 jun. 27;351(9120):1911-3.

Author

Dahl, Morten ; Tybjaerg-Hansen, A ; Lange, P ; Nordestgaard, B G. / DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. I: Lancet. 1998 ; Bind 351, Nr. 9120. s. 1911-3.

Bibtex

@article{e0013010352e415eb2cd97d8a16ccfd4,
title = "DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma",
abstract = "Cystic fibrosis is a recessive disorder mainly characterised by lung disease. We tested the hypothesis that individuals heterozygous for the common cystic fibrosis deltaF508 mutation are at risk of obstructive pulmonary disease.",
keywords = "Asthma, Cross-Sectional Studies, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Denmark, Disease Susceptibility, Female, Heterozygote, Heterozygote Detection, Humans, Male, Middle Aged, Spirometry",
author = "Morten Dahl and A Tybjaerg-Hansen and P Lange and Nordestgaard, {B G}",
year = "1998",
month = jun,
day = "27",
language = "English",
volume = "351",
pages = "1911--3",
journal = "The Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",
number = "9120",

}

RIS

TY - JOUR

T1 - DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma

AU - Dahl, Morten

AU - Tybjaerg-Hansen, A

AU - Lange, P

AU - Nordestgaard, B G

PY - 1998/6/27

Y1 - 1998/6/27

N2 - Cystic fibrosis is a recessive disorder mainly characterised by lung disease. We tested the hypothesis that individuals heterozygous for the common cystic fibrosis deltaF508 mutation are at risk of obstructive pulmonary disease.

AB - Cystic fibrosis is a recessive disorder mainly characterised by lung disease. We tested the hypothesis that individuals heterozygous for the common cystic fibrosis deltaF508 mutation are at risk of obstructive pulmonary disease.

KW - Asthma

KW - Cross-Sectional Studies

KW - Cystic Fibrosis

KW - Cystic Fibrosis Transmembrane Conductance Regulator

KW - Denmark

KW - Disease Susceptibility

KW - Female

KW - Heterozygote

KW - Heterozygote Detection

KW - Humans

KW - Male

KW - Middle Aged

KW - Spirometry

M3 - Journal article

C2 - 9654257

VL - 351

SP - 1911

EP - 1913

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9120

ER -

ID: 45524424